The Christie 2030 research programme

The Christie 2030 research programme represents a transformational £30 million investment from The Christie Charity by 2030 that will enable us to accelerate cancer research and innovation in Manchester.

This aligns with The Christie Research and Innovation strategy, where research will support us to learn from every patient, enable patients to participate in research and help us to apply our knowledge to improves the lives of patients with cancer now and in the future.

The Christie 2030 research programme aims to:

  • Realise the potential of the Paterson through seamless integration of research with clinical care
  • Grow our pipeline of Christie leaders with regional, national, and international influence
  • Accelerate research and innovation, bringing tomorrow’s treatments to patients faster

Last updated: June 2026